These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3891937

  • 1. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
    Cook MG, Rohan TE.
    J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
    [Abstract] [Full Text] [Related]

  • 2. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
    Cui Y, Page DL, Lane DS, Rohan TE.
    Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
    [Abstract] [Full Text] [Related]

  • 3. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE.
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [Abstract] [Full Text] [Related]

  • 4. Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the Women's Health Initiative.
    Cui Y, Page DL, Chlebowski RT, Hsia J, Allan Hubbell F, Johnson KC, Rohan TE.
    Cancer Causes Control; 2007 May; 18(4):431-8. PubMed ID: 17323143
    [Abstract] [Full Text] [Related]

  • 5. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA.
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [Abstract] [Full Text] [Related]

  • 6. A case-control study of diet and benign proliferative epithelial disorders of the breast.
    Rohan TE, Cook MG, Potter JD, McMichael AJ.
    Cancer Res; 1990 Jun 01; 50(11):3176-81. PubMed ID: 2334913
    [Abstract] [Full Text] [Related]

  • 7. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S.
    Clin Lab Med; 2005 Dec 01; 25(4):713-31, vi. PubMed ID: 16308088
    [Abstract] [Full Text] [Related]

  • 8. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [Abstract] [Full Text] [Related]

  • 9. A cohort study of oral contraceptive use and risk of benign breast disease.
    Rohan TE, Miller AB.
    Int J Cancer; 1999 Jul 19; 82(2):191-6. PubMed ID: 10389751
    [Abstract] [Full Text] [Related]

  • 10. Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors.
    Petrakis NL, Ernster VL, King EB, Sacks ST.
    J Natl Cancer Inst; 1982 Jan 19; 68(1):9-13. PubMed ID: 6948129
    [Abstract] [Full Text] [Related]

  • 11. Evidence for premalignant lesions in the human breast.
    Sloane JP.
    Eur J Cancer Prev; 1993 Nov 19; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract] [Full Text] [Related]

  • 12. Frequency of benign and preinvasive breast diseases.
    Altaf FJ, Abdullah LS, Jamal AA.
    Saudi Med J; 2004 Apr 19; 25(4):493-7. PubMed ID: 15083223
    [Abstract] [Full Text] [Related]

  • 13. Use of risk factors in counseling patients.
    Love SM.
    Hematol Oncol Clin North Am; 1989 Dec 19; 3(4):599-610. PubMed ID: 2691491
    [Abstract] [Full Text] [Related]

  • 14. Histological pattern of benign breast disease as a risk factor for invasive breast cancer.
    Bianchi S, del Turco MR, Simoncini R, Distante V, Russo A, Palli D.
    Cancer Detect Prev; 1992 Dec 19; 16(1):17-9. PubMed ID: 1551133
    [Abstract] [Full Text] [Related]

  • 15. Alcohol consumption and risk of benign proliferative epithelial disorders of the breast in women.
    Rohan TE, Cook MG.
    Int J Cancer; 1989 Apr 15; 43(4):631-6. PubMed ID: 2703271
    [Abstract] [Full Text] [Related]

  • 16. [Significance of proliferative breast lesions around breast cancers].
    Moriya T, Manabe T, Sakurai T, Sakamoto K.
    Gan To Kagaku Ryoho; 1995 Apr 15; 22 Suppl 1():42-5. PubMed ID: 7747991
    [Abstract] [Full Text] [Related]

  • 17. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M, Wassertheil-Smoller S, Page DL.
    J Natl Cancer Inst; 2008 Apr 16; 100(8):563-71. PubMed ID: 18398105
    [Abstract] [Full Text] [Related]

  • 18. Relation between component parts of fibrocystic disease complex and breast cancer.
    Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH.
    J Natl Cancer Inst; 1978 Oct 16; 61(4):1055-63. PubMed ID: 279711
    [Abstract] [Full Text] [Related]

  • 19. Preneoplasia of the breast.
    Böcker W.
    Verh Dtsch Ges Pathol; 1997 Oct 16; 81():502-13. PubMed ID: 9474891
    [Abstract] [Full Text] [Related]

  • 20. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.
    Page DL, Dupont WD, Jensen RA.
    Cancer Epidemiol Biomarkers Prev; 1996 Jan 16; 5(1):29-32. PubMed ID: 8770463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.